10-Q MD&A Requirements: 2026 Practitioner Walkthrough

10-Q MD&A Requirements: 2026 Practitioner Walkthrough

If your team is drafting the MD&A for a Form 10-Q, the regulatory minimum and what the SEC actually expects in practice are two different things. This walkthrough covers both: the Item 303(b) of Regulation S-K framework, the 2021 modernization changes many teams still haven't fully absorbed, and the specific comment letter patterns that turn a compliant-looking MD&A into a deficiency notice.

Key takeaway: The 10-Q MD&A is a scaled version of the annual 10-K MD&A, focused on material changes. But "scaled" does not mean minimal. The SEC's comment letter program targets quarterly filings as aggressively as annual ones, and the CEO and CFO certify the MD&A personally under SOX Sections 302 and 906.

For a broader overview of the 10-Q form itself, see Finrep's complete guide to SEC Forms 10-K, 10-Q, and 8-K. This article goes deep on the MD&A section specifically.

What Does Item 303(b) Actually Require in a 10-Q MD&A?

The 10-Q MD&A is governed by Item 303(b) of Regulation S-K, not the full Item 303 framework that applies to annual reports. The distinction matters: quarterly filers are not required to reproduce a standalone, comprehensive MD&A. They must discuss material changes.

Specifically, Item 303(b) requires:

1. Financial condition: Material changes from the end of the preceding fiscal year to the date of the most recent interim balance sheet.
2. Results of operations: Material changes for the most recent fiscal quarter and the year-to-date period, compared to the corresponding prior-year periods.
3. Liquidity and capital resources: Material changes in liquidity, including a forward-looking 12-month assessment of the registrant's ability to meet cash needs.
4. Known trends and uncertainties: Any known trends or uncertainties that have had, or are reasonably likely to have, a material impact on revenues or income from continuing operations.

Information already disclosed in the most recent annual 10-K does not need to be repeated, unless there have been material changes. Registrants may incorporate by reference from the 10-K for unchanged information, but must update anything that has changed materially, per SEC Regulation S-X Rule 10-01.

The MD&A appears as Item 2 of Part I of the Form 10-Q, immediately following the condensed financial statements.

10-Q MD&A vs. 10-K MD&A: What You Can Omit

This is the question most practitioners handle inconsistently. The table below maps what the annual 10-K requires against what the quarterly 10-Q requires.

The EY 2026 Form 10-Q guide confirms that interim MD&A is intended to be a scaled version of the annual MD&A, focused on material changes rather than a comprehensive standalone discussion.

Practical note: Many teams still use 10-K MD&A templates for their 10-Q drafts and then try to cut them down. The better approach is to start from the quarterly materiality question: what changed materially this quarter, and why?

What Changed in 2021: The Item 303 Modernization

The SEC's 2021 overhaul of Item 303 (Release No. 33-10890, effective February 10, 2021) was the most significant MD&A reform in decades. Many practitioners still haven't fully updated their templates or analytical frameworks to reflect it.

Key changes from SEC Release No. 33-10890:

• Eliminated the separately captioned off-balance-sheet arrangements section. Material off-balance-sheet arrangements must still be disclosed, but they now belong inside the Liquidity and Capital Resources discussion, not in a separate section. Many 10-Q templates still have a standalone OBS section that is now structurally incorrect.
• Eliminated the contractual obligations table. The replacement is a principles-based requirement to discuss material cash requirements from known contractual and other obligations. Registrants must now exercise judgment about what to include rather than populating a prescribed table.
• Eliminated the standalone inflation and price changes discussion. Inflation must still be discussed if it constitutes a known trend or uncertainty with material impact, but it no longer requires its own section header.
• Added an explicit disclosure objective: to provide material information necessary to an understanding of the registrant's financial condition, changes in financial condition, and results of operations. This objective-based framing is the analytical anchor for determining what to include.
• Codified the two-step framework from prior interpretive releases: (1) identify known trends, demands, commitments, events, or uncertainties; (2) assess whether they are reasonably likely to have a material effect. If the registrant cannot determine whether a trend is reasonably likely to have a material effect, it must disclose the trend and the uncertainty about its impact.
• Added the offsetting changes requirement: when material changes within a line item offset one another, the registrant must discuss the underlying reasons for the net change in both quantitative and qualitative terms, not just report the net result.

All of these changes apply to interim filings. If your 10-Q template predates February 2021, it needs a structural review.

The Interim Materiality Standard: How Quarterly Differs from Annual

Materiality in a quarterly context is not simply one-fourth of the annual materiality threshold. The EY 2026 Form 10-Q guide treats interim materiality as a distinct topic (Section 3.7.2), and for good reason.

An item that is not material on an annual basis may be material in the context of a single quarter, and vice versa. A one-time charge that represents 2% of annual revenue might represent 8% of a single quarter's revenue. Conversely, a seasonal business might show swings in a single quarter that are expected and immaterial in context.

The practical implication: run the materiality assessment at the quarterly level before deciding what to include or omit. Don't anchor to the annual thresholds you used for the 10-K.

The SEC's Comment Letter Patterns: What Actually Gets Flagged

Knowing the rules is necessary but not sufficient. The SEC's Division of Corporation Finance actively reviews 10-Q filings and issues comment letters on MD&A deficiencies. Based on Deloitte's DART roadmap on SEC comment letter considerations, the recurring patterns are specific and avoidable.

Deficiency 1: Reciting numbers without explaining them

The most common comment letter deficiency. The SEC staff has stated directly:

"Please revise your disclosures to comply with Item 303 of Regulation S-K. In doing so, please be sure to describe the reasons for significant changes in revenues, expenses, cash flows and financial position. It is not sufficient to merely recite the information that is available on the face of the financial statements without describing the events, transactions and economic changes that materially affected the reported amounts."

If your results of operations section says "revenue increased $12.3 million compared to the prior year quarter," that is a restatement of the income statement, not an MD&A. The MD&A must explain why.

Deficiency 2: Failing to quantify each contributing factor

When a change is attributed to more than one factor, each factor must be separately quantified. The SEC staff has been explicit:

"Please quantify each material component when a change is attributed to more than one factor. For example, you state that certain increases were 'primarily' attributed to one factor, or 'partially offset' by another."

Saying revenue increased "primarily due to volume growth, partially offset by pricing pressure" without dollar amounts for each factor does not satisfy Item 303(b)(2)(iii). Quantify both.

Deficiency 3: Ignoring offsetting changes within a line item

This is the 2021 addition that most practitioners miss. If gross margin declined by $5 million but that net figure reflects a $15 million increase in one cost category offset by a $10 million decrease in another, the MD&A must discuss both underlying movements, not just the net. The SEC has cited this directly under Release No. 33-10890:

"Please revise future filings to discuss the underlying reasons for material changes in quantitative and qualitative terms in all situations in which one or more line items in the financial statements reflect material changes from period to period, including those in which material changes within a line item offset one another."

Deficiency 4: Thin liquidity disclosure

The SEC has issued comment letters requiring registrants to revise their 10-Q MD&A specifically to address the 12-month forward-looking liquidity assessment:

"Please revise your MD&A in your Form 10-Q to address your capital needs for the next twelve months, the material uncertainties surrounding your liquidity."

The liquidity section must go beyond describing current cash balances and credit facilities. It must assess whether those resources are sufficient to meet obligations over the next twelve months, and identify any material uncertainties.

Deficiency 5: Generic macroeconomic boilerplate

Acknowledging inflation, supply chain disruption, or interest rate pressure in generic terms is not enough. The SEC has cited Item 303(b)(2)(ii) in comment letters requiring registrants to:

"Expand your disclosure to identify the principal factors contributing to these issues and clarify the resulting impact on you. Additionally, disclose any known trends or uncertainties regarding these issues that are reasonably likely to have a material impact on your cash flows, liquidity, capital resources, cash requirements, financial position, or results of operations."

Generic language about "macroeconomic headwinds" is a comment letter waiting to happen. Company-specific quantification of the impact is what the rule requires.

Deficiency 6: Inconsistency with earnings calls

This one surprises many teams. The SEC staff monitors earnings calls and other public communications. If your CFO discusses price inflation on the Q2 earnings call, the staff may issue a comment letter if the 10-Q MD&A does not address it with equivalent specificity:

"We note from your first quarter earnings call that the company experienced some price inflation. Please expand your discussion to identify the principal factors contributing to the inflationary pressures the company has experienced and clarify the resulting impact, if material, to the company."

The IR team and the SEC reporting team need to compare notes before the 10-Q is filed. What was said publicly must be reflected in the filing.

The 'Reasonably Likely' Threshold: Lower Than You Think

The standard for disclosing known trends and uncertainties under Item 303 is "reasonably likely" to have a material impact, not "more likely than not." This is a lower bar than many practitioners assume, and the 2021 modernization codified it.

The two-step analytical framework from Release No. 33-10890:

1. Identify known trends, demands, commitments, events, or uncertainties.
2. Assess whether they are reasonably likely to have a material effect on financial condition or results of operations.

If the registrant cannot determine whether a trend is reasonably likely to have a material effect, it must disclose the trend and the uncertainty about its impact. The inability to assess is itself a disclosure trigger.

In 2026, with interest rate volatility, persistent input cost pressures, and FX movements affecting many sectors, the question is not whether macroeconomic factors exist, but whether they are material and company-specific. If they are, they belong in the MD&A with quantification.

Non-GAAP Measures and KPIs in 10-Q MD&A

Non-GAAP financial measures appearing in the 10-Q MD&A are subject to Item 10(e) of Regulation S-K and Regulation G. The requirements:

• Present the most directly comparable GAAP measure with equal or greater prominence than the non-GAAP measure.
• Provide a quantitative reconciliation to the comparable GAAP measure.
• Explain why management believes the non-GAAP measure is useful to investors.

Key performance indicators (KPIs) disclosed in MD&A are subject to SEC Release No. 33-10751 (adopted January 30, 2020), which requires registrants to:

• Define each KPI clearly.
• Explain why it is useful to investors.
• Disclose any changes in the metric's definition or calculation method from period to period.

The 10-Q MD&A is a frequent target of SEC comment letters on non-GAAP presentation. The most common issue: a non-GAAP measure presented more prominently than its GAAP equivalent, or a reconciliation that does not trace cleanly to the financial statements. For a detailed compliance walkthrough on non-GAAP presentation, see Finrep's guide on Item 10(e) Regulation S-K compliance.

Forward-Looking Statements and the PSLRA Safe Harbor

MD&A necessarily contains forward-looking statements, particularly in the liquidity, trends, and uncertainties sections. The Private Securities Litigation Reform Act (PSLRA) safe harbor protects these statements if they are:

• Identified as forward-looking, and
• Accompanied by meaningful cautionary language identifying important factors that could cause actual results to differ materially.

The catch: boilerplate safe harbor language does not satisfy the "meaningful" standard. The cautionary language must be company-specific and current. A generic list of risk factors copied from the 10-K risk factor section, without tailoring to the specific forward-looking statements in the MD&A, is unlikely to provide robust protection.

The safe harbor also does not apply to statements made in connection with an initial public offering. For newly public companies navigating their first 10-Q filings, see Finrep's post-IPO reporting requirements walkthrough.

SOX Certifications: Why MD&A Accuracy Is a C-Suite Issue

Every 10-Q requires certifications from the CEO and CFO under Sarbanes-Oxley Sections 302 and 906, per the EY 2026 Form 10-Q guide. The Section 302 certification requires the signing officers to confirm, among other things, that the MD&A and other disclosures fairly present in all material respects the financial condition and results of operations.

This creates direct personal liability for MD&A accuracy and completeness. A deficient MD&A is not just a disclosure team problem. It is a problem the CEO and CFO have personally certified away.

For teams using AI tools to accelerate MD&A drafting, Finrep's AI MD&A drafting automation walkthrough covers the SOX 302 workflow and governance requirements in detail.

10-Q Filing Deadlines for 2026

Deadlines depend on filer status, determined by public float as of the last business day of the second fiscal quarter, per the EY 2026 Form 10-Q guide:

No 10-Q is required for the fourth fiscal quarter. The annual Form 10-K covers that period. A late filing without a timely Form 12b-25 can cost the registrant Form S-3 eligibility.

How to Benchmark Your MD&A Against SEC Expectations

One underused tool: the SEC's own comment letter database on EDGAR. After the review process concludes, the SEC publishes its comment letters and company responses. You can search for comment letters in your industry using EDGAR full-text search by filtering for "UPLOAD" and "CORRESP" filing types.

Reading comment letters from peer companies in your sector tells you exactly what the SEC staff is currently scrutinizing in MD&A disclosures. It is free, authoritative, and almost entirely unused by most reporting teams.

For teams that want to systematize the results of operations commentary process, Finrep's MD&A flux commentary automation guide and the companion article on results of operations disclosure practices that reduce SEC comments cover the workflow in detail.

FAQ

Are 10-Qs mandatory for all public companies? Yes. Any domestic registrant subject to the Securities Exchange Act of 1934 must file a Form 10-Q for each of the first three fiscal quarters of its fiscal year. There is no fourth-quarter 10-Q; the annual 10-K covers that period.

Can I incorporate by reference from my 10-K to avoid repeating MD&A disclosures? Yes, for information that has not materially changed. If a risk factor, accounting policy, or other disclosure from the 10-K remains accurate and unchanged, you may incorporate it by reference rather than repeating it. But any information that has changed materially must be updated in the 10-Q itself.

Does the 10-Q MD&A need to discuss every line item in the income statement? No. The requirement is to discuss material changes. If a line item did not change materially, or if the change is self-evident from the financial statements, a detailed discussion is not required. The judgment call is what is material in the quarterly context, which may differ from the annual materiality threshold.

Is the contractual obligations table still required in a 10-Q? No. The SEC eliminated the contractual obligations table in the 2021 Item 303 modernization (Release No. 33-10890, effective February 10, 2021). The replacement is a principles-based requirement to discuss material cash requirements from known contractual and other obligations. If your template still has a prescribed table, update it.

What happens if the SEC issues a comment letter on our 10-Q MD&A? The company must respond in writing, typically within 10 business days of the comment letter date. Responses are filed on EDGAR as "CORRESP" documents. The SEC staff may require the company to amend the 10-Q, revise disclosures in future filings, or both. Unresolved comments must be disclosed in the next annual 10-K under Item 1B.

Do segment-level results need to be discussed separately in the 10-Q MD&A? Generally yes, if segment-level results are material and differ meaningfully from consolidated trends. The SEC has issued comment letters requiring separate discussion of segment performance when consolidated MD&A obscures material divergence between segments. The test is whether a reasonable investor would find the segment-level information material to understanding the company's results.